Inso Biosciences
PrivateLast Round
Grant
Jun 24, 2026
Total Funding Raised
$5.91M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Inso Biosciences is a biotechnology company that develops a cell sample preparation platform designed for genomic analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inso Biosciences Comparables
Compare Inso Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MicroPure Genomics Inc. | 88% | |
| Sage Science | 74% | |
| SIRION Biotech | 73% |
Inso Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 24, 2026 | ||||
| Seed Round | Apr 10, 2026 | ||||
| Accelerator | Jun 10, 2025 | ||||
| Grant | Jul 1, 2023 | ||||
| Grant | Nov 8, 2022 | ||||
Grant | Sep 19, 2022 |
Key People
Founding team and executive leadership
Inso Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Empire State Development | Grant |
| FuzeHub | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| IndieBio | Pre Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$750K raised in Seed Round.
- Sep 19, 2022
$400K grant received from Empire State Development and National Cancer Institute.
Inso Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inso Biosciences's valuation, stock price, and market status.
Is Inso Biosciences a public or private company?
Inso Biosciences is a private company.
What is the current stock price of Inso Biosciences?
Inso Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Inso Biosciences worth (valuation)?
Valuation information for Inso Biosciences is not publicly available.
Can I buy Inso Biosciences stock?
Inso Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inso Biosciences's last funding round?
Inso Biosciences's most recent funding round was Seed Round on April 10, 2026.
Who are the main investors in Inso Biosciences?
Key investors in Inso Biosciences include 2048 Ventures.
Will Inso Biosciences IPO soon?
No public IPO plans have been announced for Inso Biosciences.
How can I track Inso Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inso Biosciences's secondary market activity and sign up for updates.